Bio Protocol vs Slash Vision Labs — how do they compare? Bio Protocol trades at Rp436.75 (market cap Rp997,43M, Rp162,4M 24h volume), while Slash Vision Labs trades at Rp59.23 (market cap --, Rp2,5M 24h volume). The key difference: Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while Slash Vision Labs's keeps growing, and Bio Protocol is more actively traded (Rp162,4M versus Rp2,5M). Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Slash Vision Labs for 10 Days on average.
| BIO | SVL | |
|---|---|---|
Market Cap | Rp997,43M | -- |
Volume (24h) | Rp162,4M | Rp2,5M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | -- |
Typical Hold Time | 18 Days | 10 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
SVL is currently trading at Rp 58.913, exhibiting a mixed technical picture with a bullish overall signal but bearish moving averages. Key resistance lies at Rp 65 (R1) with support at Rp 56 (S1). The token's max supply is capped at 10 million, and the average hold time is 10 days, indicating relatively short-term holding patterns. No major recent protocol updates or ecosystem news were identified.
The outlook is cautiously optimistic due to bullish oscillators, but risks include high volatility and proximity to resistance. Key opportunities lie in a breakout above Rp 65, while major risks are the bearish moving average trend and low liquidity. Investors should monitor volume and on-chain activity closely.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Slash Vision Labs is a cryptocurrency payments platform designed to simplify the use of digital assets in everyday transactions. As the creator of Japan's first compliant crypto-backed credit card, Slash Vision Labs bridges the gap between traditional finance and digital currencies. The Slash Card, along with the SVL token, serves as an entry point for new users in Japan who are exploring the world of cryptocurrency. By offering secure, self-custodial payment solutions, Slash Vision Labs makes it easier to integrate cryptocurrency into daily life.
Read more on SVL →